JPS61129118A - Elastic plaster - Google Patents

Elastic plaster

Info

Publication number
JPS61129118A
JPS61129118A JP25074084A JP25074084A JPS61129118A JP S61129118 A JPS61129118 A JP S61129118A JP 25074084 A JP25074084 A JP 25074084A JP 25074084 A JP25074084 A JP 25074084A JP S61129118 A JPS61129118 A JP S61129118A
Authority
JP
Japan
Prior art keywords
layer
drug
adhesive layer
plaster
urethane foam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP25074084A
Other languages
Japanese (ja)
Inventor
Takao Maruoka
丸岡 孝雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIA SEIYAKU KK
Original Assignee
DIA SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIA SEIYAKU KK filed Critical DIA SEIYAKU KK
Priority to JP25074084A priority Critical patent/JPS61129118A/en
Publication of JPS61129118A publication Critical patent/JPS61129118A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:A plaster having improved expanding and contracting properties, drug releas ing effect, durability of medicinal effect, etc., obtained by forming a drug retaining layer consisting of a high-viscosity gelatinous base on one side (inner part layer) of elastic urethane foam, and laminating a pressure-sensitive adhesive layer in contact with the layer on it. CONSTITUTION:The drug retaining layer 2 consisting of a high-viscosity gelatinous base containing a drug such as methyl salicylate, etc. is formed on the inner part layer of one side of the substrate 1 comprising the elastic open-cell foamed urethane foam by a means such as packing, impregnation, etc. Further, the water-soluble or water-insoluble pressure-sensitive adhesive layer 3 is laminated to the layer in such a way that the drug retaining layer 2 is laminated to the layer in such a way that the adhesive layer is directly brought into contact with the drug retaining layer 2, to give an elastic plaster capable of keeping common adherent feeling by expansion and contraction of the substrate 1 even if this plaster is applied to the expanding and contracting part of the skin, having and improved drug releasing effect and durability of medicinal effect because of double layer structure of the drug retaining layer 2 and the pressure-sensitive adhesive layer 3. Before the plaster is used, the pressure- sensitive adhesive layer 3 is protected with the release layer 4.

Description

【発明の詳細な説明】 (産業上の利用分野) この発明は、特に伸縮性に富んだ皮膚面に貼付ける貼付
剤に関する。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a patch that is particularly highly elastic and is applied to the skin surface.

(従来の技術) 従来の貼付剤は、リント布、不織布、プラスチックフィ
ルム等の伸縮性、通気性及び保温性に比較的乏しい支持
体に単層基剤を展伸したものである(発明が解決しよう
とした問題点) 貼付剤の貼付個所が皮膚の屈伸部又は伸縮部である場合
剥がれ易い、従来の貼付剤を皮膚の屈伸部又は伸縮部に
通用するには固定用の包帯、絆創膏、サージカルテープ
等を併用しなければならない。この欠点を除去するため
貼付面が非水溶性基剤としてその接着力を強力にするこ
とが考えられるが、このような貼付剤を皮膚の伸縮部に
貼付した場合、貼付剤の薬物放出性に欠けると共に貼り
付は皮膚表面に引張り感がつよくなり色部に不快感が伴
うという問題がある。
(Prior art) Conventional patches are made by spreading a single-layer base on a support such as lint cloth, nonwoven fabric, or plastic film that has relatively poor elasticity, breathability, and heat retention. (Problems that the patch is applied to) When the patch is applied to a bending or stretching area of the skin, it tends to peel off easily.In order to apply a conventional patch to the bending or stretching area of the skin, a fixing bandage, bandage, or surgical tape is required. etc. must be used together. In order to eliminate this drawback, it is possible to strengthen the adhesive force by using a water-insoluble base on the patch surface, but when such a patch is applied to an elastic part of the skin, the drug release properties of the patch may be affected. In addition to chipping, adhesion causes a strong tensile feeling on the skin surface, causing discomfort in the colored areas.

このような貼付剤におけるプラスチックフィルム、リン
ト布、不織布、のような支持体では通気性の調節、表面
温度の調節等はできない。
With supports such as plastic films, lint cloths, and nonwoven fabrics in such patches, it is not possible to adjust air permeability, surface temperature, etc.

この発明は、上記の問題点を解決することをその目的と
したものである。
This invention aims to solve the above problems.

(問題点を解決するための手段) この発明の構成を、以下図面に示す実施例に従って説明
する。
(Means for Solving the Problems) The configuration of the present invention will be described below according to embodiments shown in the drawings.

第1図は、この発明の構成を示す伸縮性貼付剤(a)の
断面図である。(1)は伸縮自在の軟質性ウレタンフオ
ームであって、仁の伸縮性貼付剤の支持体としたもので
、貼付剤の支持体としてその厚さは約2mm程度が適当
である。
FIG. 1 is a sectional view of a stretchable adhesive patch (a) showing the structure of the present invention. (1) is a flexible, stretchable urethane foam that is used as a support for a stretchable patch, and the appropriate thickness for the support for the patch is about 2 mm.

該ウレタンフオームの片面の内部層に下記の配合例から
なる高粘度ゲル状基剤を、ウレタンフオームのセル(細
孔)に充填又は含浸等の手段により薬物保持層(2)を
形成せしめる。
A drug-retaining layer (2) is formed in the inner layer on one side of the urethane foam by filling or impregnating the cells (pores) of the urethane foam with a high viscosity gel base having the formulation shown below.

実施例1 層厚100〜500 g/m” とした高粘度ゲル状基
剤の配合例(重量基準)を示す。
Example 1 A formulation example (by weight) of a high viscosity gel base having a layer thickness of 100 to 500 g/m'' is shown.

ゼラチン          5部 CMC−ナトリウム      2部 ポリアクリル酸ナトリウム   1部 グリセリン        20部 水                     72f
B上記の配合例からなる高粘度ゲル状基剤を前記ウレタ
ンフオームの片面のセル(細孔)に充填又は含浸等の手
段により薬物保持層を形成せしめこれをゲル化した後、
更にこの薬物保持層と直接接触するように水溶性又は非
水溶性の粘着層(3)を前記ウレタンフオームの片面に
積層せしめる。
Gelatin 5 parts CMC-sodium 2 parts Sodium polyacrylate 1 part Glycerin 20 parts Water 72f
B: After forming a drug-retaining layer by filling or impregnating cells (pores) on one side of the urethane foam with a high-viscosity gel-like base consisting of the above formulation example, and gelling this,
Further, a water-soluble or water-insoluble adhesive layer (3) is laminated on one side of the urethane foam so as to be in direct contact with the drug-retaining layer.

尚、(4)は販売時又は非使用時に粘着層(3)を保護
するための剥離自在のプラスチックフィルムのような@
離層である。
In addition, (4) is a removable plastic film to protect the adhesive layer (3) when sold or not in use.
It is delamination.

水溶性又は非水溶性の粘着層(3)の基剤の配合例は以
下に例示する如くである。
Examples of the formulation of the base for the water-soluble or water-insoluble adhesive layer (3) are as shown below.

実施例2 層厚100〜500 g/m”とした水溶性粘着基剤の
配合例は以下の通りである。
Example 2 A formulation example of a water-soluble adhesive base having a layer thickness of 100 to 500 g/m is as follows.

ゼラチン          2部 ポリビニルアルコール     2B ポリアクリル酸ナトリウム   5IIICMC−ナト
リウム      4部 カオリン            1部ポリブテン  
        1部 グリセリン        20部 水                    65B実
施例3 層厚50〜200g/m”とした非水溶性粘着基剤の配
合例は以下の通りである。
Gelatin 2 parts Polyvinyl alcohol 2B Sodium polyacrylate 5IIICMC-sodium 4 parts Kaolin 1 part Polybutene
1 part glycerin 20 parts water 65B Example 3 A formulation example of a water-insoluble adhesive base having a layer thickness of 50 to 200 g/m'' is as follows.

生ゴム           52部 エステルガム        20! ポリブテン         103ftエスコレノツ
        15部 流動パラフィン        3部 以下、本発明にかかる貼付剤と公知の貼付剤との薬物の
移動速度を比較実験を示すデーターを示す本発明にかか
る貼付剤として上記実施例[の配合による高粘度ゲル状
基剤にサルチル酸メチル2パーセント配合したものをウ
レタンフオームの片面のセル(11孔)に層厚500 
g/m”で充填又は含浸等の手段により薬物保持N(2
)を形成せしめこれをゲル化した後前記実施例3の非水
溶性粘着基剤をFIN100g/m”を積層した検体を
使用した。
Raw rubber 52 parts Ester gum 20! Polybutene 103 ft Escolenots 15 parts Liquid paraffin 3 parts or less Data showing a comparative experiment of drug transfer speed between the patch according to the present invention and a known patch. A high viscosity gel base containing 2% methyl salicylate was applied to the cells (11 pores) on one side of the urethane foam to a thickness of 500.
Drug retention N(2
) was formed into a gel, and then the water-insoluble adhesive base of Example 3 was laminated with FIN100 g/m''.

一方、対照薬として使用したものは、以下の配合の基剤
にサルチル酸メチル2パーセントを配合し、これを不織
布に層厚500 g/m”展伸した検体である。
On the other hand, the control drug used was a sample in which 2% methyl salicylate was blended into the base of the following formulation, and this was spread onto a non-woven fabric to a layer thickness of 500 g/m''.

対照薬の基剤の配合割合 ゼラチン           6B ポリビニルアルコール     5部 ポリアクリル酸ナトリウム   IB CMC−ナトリウム      2B カオリン           2部 ポリブテン          2部 グリセリン        30B 水                   52部上記
の貼付剤を同面積(1・5−)の断片をノヤーレ中で5
パーセントの寒天ゲル(i径10cm、高さ5m)Fl
を作成し、摂氏37度中でこの中央にこれらの検体を配
置せしめ、2時間毎に7天ゲル層を取替え、寒天ゲル中
のサルチル酸メチルを常法により測定し、その時間内の
移動薬物量としたものである。
Compounding ratio of base of control drug Gelatin 6B Polyvinyl alcohol 5 parts Sodium polyacrylate IB CMC-sodium 2B Kaolin 2 parts Polybutene 2 parts Glycerin 30B Water 52 parts 5 in Noyale
Percent agar gel (i diameter 10cm, height 5m) Fl
The samples were placed in the center of the agar gel at 37 degrees Celsius, the seven gel layers were replaced every 2 hours, and the methyl salicylate in the agar gel was measured using a conventional method. It is expressed as a quantity.

その結果は第2図のように薬物の放出効果、薬効の+*
s:を性に!!fluffな差異をしめしたものである
The results show the drug release effect and drug efficacy as shown in Figure 2.
s: to sex! ! This shows the fluff difference.

(作用) この発明の伸縮性貼付剤を皮膚の屈伸部又は伸縮部に適
用した場合支持体の伸縮によって一旦貼着した貼付剤は
皮膚の伸縮と共にし、身体の移動により皮膚が伸張した
場合でも平常の貼着層を維持できる。
(Function) When the stretchable patch of this invention is applied to a bending or stretching part of the skin, the patch once applied will expand and contract as the skin expands and contracts due to the expansion and contraction of the support, and even if the skin stretches due to movement of the body. A normal adhesive layer can be maintained.

また、薬物保持層と粘着層との二層構造としであるので
薬物の放出効果に優れると共に薬効の持続性もある。
Furthermore, since it has a two-layer structure consisting of a drug-retaining layer and an adhesive layer, it has excellent drug release effects and long-lasting drug efficacy.

(発明の効果) この発明は、伸縮自在のウレタンフオームを保持層とな
し、該ウレタンフオームの片面の内部層に高粘度ゲル吠
基剤からなる薬物保持層を形成せしめると共にこのウレ
タンフオームの片面には前記薬物保持層と直接接触する
ように水溶性又は非水溶性粘着層を積層しであるので、
貼着時に皮膚に対して接触感がよく而も皮膚の可動部に
貼付しても皮膚に緊張感もなく包帯、絆創膏、サージカ
ルテープ等の固定用品も不用である。
(Effects of the Invention) This invention uses a stretchable urethane foam as a retention layer, forms a drug retention layer made of a high viscosity gel base on the inner layer on one side of the urethane foam, and forms a drug retention layer on one side of the urethane foam. has a water-soluble or water-insoluble adhesive layer laminated in direct contact with the drug-retaining layer;
When applied, it has a good contact feeling to the skin, and even when applied to a moving part of the skin, there is no feeling of tension on the skin, and fixing supplies such as bandages, adhesive plasters, and surgical tape are not required.

さらに、薬物保持層と粘着層との二層構造としであるの
で薬物の放出効果に優れると共に薬効の持続性にも顕著
な効果があるものである。
Furthermore, since it has a two-layer structure consisting of a drug-retaining layer and an adhesive layer, it has an excellent drug release effect and a remarkable effect on the sustainability of drug efficacy.

【図面の簡単な説明】[Brief explanation of drawings]

図面はこの発明の実施例を示すもので、□第1図は伸縮
性貼付剤の拡大断面図、第2図は貼付剤の基剤層内の移
動サルチル酸量を示すグラフである。 fa+・・伸縮性ハップ剤 il+・・ウレタンフオー
ム(2)・・薬物保持層   (3)・・貼着層(4:
・・プラスチックフィルム 以上
The drawings show examples of the present invention; □ Fig. 1 is an enlarged sectional view of a stretchable patch, and Fig. 2 is a graph showing the amount of salicylic acid transferred in the base layer of the patch. fa+...Stretchable poultice il+...Urethane foam (2)...Drug retention layer (3)...Adhesive layer (4:
・More than plastic film

Claims (2)

【特許請求の範囲】[Claims] (1)伸縮自在のウレタンフォームを保持層となし、該
ウレタンフォームの片面の内部層に高粘度ゲル状基剤か
らなる薬物保持層を形成せしめると共にこのウレタンフ
ォームの片面には前記薬物保持層と直接接触するように
水溶性又は非水溶性粘着層を積層してなることを特徴と
した伸縮性貼付剤。
(1) A stretchable urethane foam is used as a retention layer, and a drug retention layer made of a high viscosity gel base is formed on the inner layer on one side of the urethane foam, and the drug retention layer is formed on one side of the urethane foam. A stretchable adhesive patch comprising a water-soluble or water-insoluble adhesive layer laminated so as to be in direct contact with each other.
(2)ウレタンフォームは連続気泡性であることを特徴
とした特許請求の範囲第1項記載の伸縮性貼付剤。
(2) The stretchable adhesive patch according to claim 1, wherein the urethane foam is open-celled.
JP25074084A 1984-11-27 1984-11-27 Elastic plaster Pending JPS61129118A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25074084A JPS61129118A (en) 1984-11-27 1984-11-27 Elastic plaster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25074084A JPS61129118A (en) 1984-11-27 1984-11-27 Elastic plaster

Publications (1)

Publication Number Publication Date
JPS61129118A true JPS61129118A (en) 1986-06-17

Family

ID=17212333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25074084A Pending JPS61129118A (en) 1984-11-27 1984-11-27 Elastic plaster

Country Status (1)

Country Link
JP (1) JPS61129118A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007029638A (en) * 2005-07-29 2007-02-08 Daiya Seiyaku Kk Cooling sheet and portable cooling sheet

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007029638A (en) * 2005-07-29 2007-02-08 Daiya Seiyaku Kk Cooling sheet and portable cooling sheet

Similar Documents

Publication Publication Date Title
US4977892A (en) Wound dressing with hydrophilic absorbent layer
US4838253A (en) Silicone gel coated permeable wound dressing
RU2597566C2 (en) Superabsorbing thin adhesive bandage, its application in treating chronic injuries
CA2030593C (en) Multi-layered dressing
US7063859B1 (en) Barrier film lined backing layer composition and method for topical administration of active agents
CA2062805C (en) Adhesive dressings
RU2586313C2 (en) Absorbent hydrocellulose dressing, use thereof in treating chronic and acute lesions
CA1209003A (en) Wound dressing, manufacture and use
EP0230387A3 (en) Foam bandage
JPH021507B2 (en)
JPS6045522B2 (en) cosmetic tools
JPS6187549A (en) Adhesive dressing and it production and use
US5921948A (en) Surgical dressing
EP2747723A2 (en) Activated carbon containing wound dressing
EP0304536A2 (en) Polymeric wound dressings
JPS5957654A (en) Low stickiness wound dressing
JP2020096956A (en) Wound dressing assembly
JP4171108B2 (en) Skin patch and method for producing the same
JP2003313110A (en) Skin pressure-sensitive adhesive sheet
JPH0761938B2 (en) Lumbago patch
CA2288482A1 (en) Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis
EP1267763B1 (en) Novel wound dressing, process of manufacture and useful articles thereof
JPS61129118A (en) Elastic plaster
NO167436B (en) A wound dressing.
JPH0724001A (en) First-aid adhesive plaster with ointment